Coronavirus – call within H2020 for rapid action

Considering that this is a newly identified virus, the scope of this expression of interest remains broad and may include topics such as:

• Development of therapeutics, including monoclonal antibodies. As relevant, evidence of regulatory and ethics approvals for the investigational products included in the study(ies) must be presented.
• Development of point of care diagnostics, ensuring rapid evaluation of candidates based on existing technologies, to allow for fast case detection and surveillance.
• Clinical and epidemiological studies, to provide data on epidemiological characteristics such as viral genotype and pathogenicity; clinical information on host susceptibility and host immune responses; risk factors for severe disease; routes of transmission and their relative importance; identification of the animal reservoir; etc.
• Social sciences research, to provide urgently needed answers to social dynamics of the outbreak and the related public health response.
  

The proposals for the call must be timely, with rapid activation, to enable early and valuable outcomes to be established.

To the call Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic on the European Commission website